Published in:
01-12-2020 | Computed Tomography | Correspondence
Lack of benefit from low dose computed tomography in screening for lung cancer - comment on paper by Huang K-L et al.
Published in: BMC Pulmonary Medicine | Issue 1/2020
Login to get accessAbstract
The article by Huang K-L et al. Effects of low-dose computed tomography (LDCT) screening on lung cancer contains a conclusion that is not consistent with the data presented. With reference to the National Lung Screening Trial (NLST) there are several flaws in the methodology overlooked. Also there is no significant reduction in deaths from all causes following the screening. Therefore any claim that the LDCT screening is superior to usual care is invalid.